다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

MYOG

Myogen (MYOG)

Myogen

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MYOG

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2006/11/18	06:02	Business Wire	Gilead Sciences Completes Acquisition of Myogen	NASDAQ:MYOG	Myogen
2006/11/06	22:00	Business Wire	Darusentan Data to Be Presented at AHA 2006 -- Chicago	NASDAQ:MYOG	Myogen
2006/10/18	05:00	Business Wire	Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan	NASDAQ:MYOG	Myogen
2006/10/10	21:00	Business Wire	Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City	NASDAQ:MYOG	Myogen
2006/10/03	01:11	PR Newswire (US)	Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG	NASDAQ:MYOG	Myogen
2006/10/02	20:00	Business Wire	Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion	NASDAQ:MYOG	Myogen
2006/09/20	21:30	Business Wire	Myogen to Present at the UBS Global Life Sciences Conference	NASDAQ:MYOG	Myogen
2006/09/07	21:00	Business Wire	Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension	NASDAQ:MYOG	Myogen
2006/09/06	21:00	Business Wire	The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational Partnership	NASDAQ:MYOG	Myogen
2006/08/08	05:00	Business Wire	Myogen Reports 2006 Second Quarter Results	NASDAQ:MYOG	Myogen
2006/07/25	20:45	Business Wire	Myogen to Announce 2006 Second Quarter Results on August 7, 2006	NASDAQ:MYOG	Myogen
2006/07/11	21:30	Business Wire	Myogen Announces Extension of Drug Discovery Collaboration	NASDAQ:MYOG	Myogen
2006/06/08	20:30	Business Wire	Myogen to Present at the Goldman Sachs Global Healthcare Conference	NASDAQ:MYOG	Myogen
2006/06/05	21:01	Business Wire	Myogen Initiates Phase 3 Clinical Trial of Darusentan in Patients with Resistant Hypertension	NASDAQ:MYOG	Myogen
2006/05/24	19:30	Business Wire	Ambrisentan Phase 3 ARIES-2 PAH Data Presented At ATS 2006 -- San Diego; Significant Improvement in Six-Minute Walk Distance an	NASDAQ:MYOG	Myogen
2006/05/08	20:00	Business Wire	Myogen Reports 2006 First Quarter Results	NASDAQ:MYOG	Myogen
2006/05/04	05:00	Business Wire	Myogen Reports Results for the Integrated Analysis of ARIES-1 and ARIES-2 Pivotal Trials of Ambrisentan in Pulmonary Arterial H	NASDAQ:MYOG	Myogen
2006/04/21	20:00	Business Wire	Myogen to Announce 2006 First Quarter Results on May 8, 2006	NASDAQ:MYOG	Myogen
2006/04/20	05:00	Business Wire	Myogen to Present at the Leerink Swann Vascular Modlulation Conference	NASDAQ:MYOG	Myogen
2006/04/11	01:36	PR Newswire (US)	Seven Summits Research releases comments on AAPL, EBAY, HAL, MYOG, and URBN	NASDAQ:MYOG	Myogen
2006/04/10	20:00	Business Wire	Myogen Reports Positive Top Line Results for Second Ambrisentan Pivotal Phase 3 Trial in Pulmonary Arterial Hypertension; ARIES	NASDAQ:MYOG	Myogen
2006/03/10	00:57	PR Newswire (US)	Seven Summits Research Releases Comments on MRVL, DELL, SGP, GENZ, and MYOG	NASDAQ:MYOG	Myogen
2006/03/09	22:00	Business Wire	Ambrisentan Receives FDA Fast Track Designation for PAH Development	NASDAQ:MYOG	Myogen
2006/03/07	06:10	Business Wire	Myogen Reports 2005 Results	NASDAQ:MYOG	Myogen
2006/03/02	22:00	Business Wire	Ambrisentan ARIES-2 Data to Be Presented at ATS 2006 -- San Diego	NASDAQ:MYOG	Myogen
2006/03/01	06:00	Business Wire	Myogen to Present at the Citigroup Small & Mid-Cap Conference	NASDAQ:MYOG	Myogen
2006/02/13	22:30	PR Newswire (US)	Myogen Reports Positive Top Line Results for Ambrisentan LFT Rescue Study In Pulmonary Arterial Hypertension	NASDAQ:MYOG	Myogen
2006/02/07	00:12	PR Newswire (US)	NASDAQ Hosts First-Ever Investor Conference in London for Small Cap Companies	NASDAQ:MYOG
2006/02/06	22:00	PR Newswire (US)	Myogen to Announce 2005 Results on March 6, 2006	NASDAQ:MYOG	Myogen
2006/02/03	06:30	PR Newswire (US)	Myogen Announces Sale of Myogen GmbH	NASDAQ:MYOG	Myogen

검색 관련기사 보기:NASDAQ:MYOG

1 2 3 4 다음 >>

BNP Paribas (QX)

Energy Select Sector SPDR

US Dollar vs Yen

Verizon Communications

Gold vs US Dollar

American Express

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관